You have 9 free searches left this month | for more free features.

CNS Metastases

Showing 1 - 25 of 3,679

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Metastatic Cancer, Brain Metastases Trial in Camden (Stereotactic Radiosurgery)

Withdrawn
  • Metastatic Cancer
  • Brain Metastases
  • Stereotactic Radiosurgery
  • Camden, New Jersey
    MD Anderson Cancer Center at Cooper
Dec 21, 2021

Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Melanoma, Pathologic Stage IV Cutaneous Melanoma AJCC v8 Trial in

Recruiting
  • Clinical Stage IV Cutaneous Melanoma AJCC v8
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 9, 2022

Malignant Melanoma, Brain Metastases Trial in Tucson (E6201, E6201 plus dabrafenib)

Terminated
  • Malignant Melanoma
  • Brain Metastases
  • Tucson, Arizona
    University of Arizona Cancer Center
Mar 5, 2022

Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Malignant Tumor in the Brain, Metastatic Malignant Tumor in the CNS

Recruiting
  • Clinical Stage IV Cutaneous Melanoma AJCC v8
  • +3 more
  • Scottsdale, Arizona
  • +2 more
Jan 4, 2023

Non Small Cell Lung Cancer Trial in China (AZD3759)

Completed
  • Non Small Cell Lung Cancer
  • Guangzhou, Guangdong, China
  • +3 more
Nov 22, 2022

NSCLC, EGFR Gene Mutation, Brain Metastases Trial in Worldwide (AZD3759, Erlotinib, Gefitinib)

Completed
  • Non-small Cell Lung Cancer
  • +2 more
  • Hefei, Anhui, China
  • +57 more
Nov 18, 2022

Breast Cancer, Brain Metastases, HER2-positive Breast Cancer Trial in Los Angeles (Tucatinib, Pembrolizumab, Trastuzumab)

Withdrawn
  • Breast Cancer
  • +3 more
  • Los Angeles, California
    Cedars-Sinai Medical Center
Jun 28, 2022

Radiotherapy, Brain Metastases, Sensitivity Trial in Lund (Brain metastases radiation)

Recruiting
  • Radiotherapy
  • +3 more
  • Brain metastases radiation
  • Lund, Sweden
    Lund University Hospital
Jan 5, 2021

Neuroblastoma, CNS Metastases, Leptomeningeal Metastases Trial in Worldwide (131I-omburtamab)

Recruiting
  • Neuroblastoma
  • +2 more
  • 131I-omburtamab
  • Los Angeles, California
  • +11 more
Dec 17, 2021

Breast Cancer, Brain Metastases Trial (Neratinib)

Withdrawn
  • Breast Cancer
  • Brain Metastases
  • (no location specified)
Feb 28, 2022

Metastatic Non Small Cell Lung Cancer, Recurrent Non Small Cell Lung Cancer Trial in United States (Amivantamab, Lazertinib)

Recruiting
  • Metastatic Non Small Cell Lung Cancer
  • Recurrent Non Small Cell Lung Cancer
  • Basking Ridge, New Jersey
  • +6 more
Aug 1, 2022

Advanced Cancer, Brain Metastases Trial in New Orleans (DM-CHOC-PEN)

Completed
  • Advanced Cancer
  • Brain Metastases
  • New Orleans, Louisiana
    Tulane University Medical Center
Nov 3, 2022

Brain Metastases, CNS Tumor, CNS Disorder, Intracranial Trial in Australia, United States (Stereotactic radiosurgery)

Recruiting
  • Brain Metastases
  • +2 more
  • Stereotactic radiosurgery
  • Birmingham, Alabama
  • +4 more
Jul 13, 2022

Metastatic Breast Cancer, CNS (CNS) Metastases Trial in United States (Lapatinib in Tandem With Capecitabine)

Completed
  • Metastatic Breast Cancer
  • Central Nervous System (CNS) Metastases
  • Lapatinib in Tandem With Capecitabine
  • Ann Arbor, Michigan
  • +8 more
Jan 25, 2021

HER2-positive Metastatic Breast Cancer, CNS Metastases Trial in Chicago, Boston (ATEZOLIZUMAB, PERTUZUMAB, TRASTUZUMAB)

Active, not recruiting
  • HER2-positive Metastatic Breast Cancer
  • Central Nervous System Metastases
  • Chicago, Illinois
  • +1 more
Mar 14, 2022

Glioblastoma, Brain Metastases Trial in Phoenix (ceritinib 750mg)

Completed
  • Glioblastoma
  • Brain Metastases
  • ceritinib 750mg
  • Phoenix, Arizona
    Barrow Brain and Spine
Dec 10, 2020

Lung Cancer, NSCLC, Brain Metastases Trial (Alectinib, Stereotactic Radiosurgery)

Not yet recruiting
  • Lung Cancer
  • +2 more
  • (no location specified)
Aug 4, 2023

NSCLC Trial in Worldwide (Entrectinib, Crizotinib)

Recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Barretos, SP, Brazil
  • +66 more
Jan 27, 2023

Non Small Cell Lung Cancer, Brain Metastases Trial in Seoul (Dacomitinib)

Recruiting
  • Non Small Cell Lung Cancer
  • Brain Metastases
  • Seoul, Korea, Republic of
    Jong-Mu Sun
Jan 1, 2021

NSCLC Trial in Changsha (Furmonertinib)

Recruiting
  • Non-Small Cell Lung Cancer
  • Changsha, Hunan, China
    Hunan Cancer hospital
May 19, 2022

Metastatic Lung Non-Small Cell Carcinoma, Metastatic Malignant Tumor in the Brain, Stage IV Lung Cancer AJCC v8 Trial in Duarte

Not yet recruiting
  • Metastatic Lung Non-Small Cell Carcinoma
  • +2 more
  • Biospecimen Collection
  • +4 more
  • Duarte, California
    City of Hope Medical Center
May 1, 2023

NSCLC, Brain Tumors Trial (bevacizumab, First-Line Chemotherapy Agents, Second-Line Chemotherapy Agents)

Completed
  • Non-Small Cell Lung Cancer
  • Brain Neoplasms
  • (no location specified)
Dec 9, 2022

Breast Cancer Metastatic Trial in Spain (Irinotecan Hydrochloride)

Recruiting
  • Breast Cancer Metastatic
  • Irinotecan Hydrochloride
  • Badalona, Spain
  • +19 more
Jan 18, 2023

NSCLC Trial (Cobicistat)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • (no location specified)
Feb 17, 2023

Breast Cancer, Metastatic Breast Cancer Trial (Trastuzumab-Deruxtecan (T-DXd))

Not yet recruiting
  • Breast Cancer
  • Metastatic Breast Cancer
  • Trastuzumab-Deruxtecan (T-DXd)
  • (no location specified)
Sep 20, 2023